Several Brokerage Firms Initiate Coverage on Talecris Biotherapeutics (TLCR)
Tweet Send to a Friend
J.P. Morgan initiates coverage on Talecris Biotherapeutics (Nasdaq: TLCR) with an Overweight.
Goldman initiates coverage ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman initiates coverage ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
